Simcere Pharmaceutical Group Limited (2096.HK)
HKD 6.71
(-2.33%)
HKD 6.71
(-2.33%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 151.04 Million | 1.35 Billion | -201.97 Million | 96.73 Million | 772.8 Million | 775.81 Million |
| Net Income | 740.03 Million | 888.15 Million | 1.4 Billion | 805.08 Million | 1.08 Billion | 929.04 Million |
| Depreciation & Amortization | 309.59 Million | 282.92 Million | 251.8 Million | 222.32 Million | 162.5 Million | 120 Million |
| Deferred income taxes | - | -8.27 Million | -1.11 Billion | -574.64 Million | -265.76 Million | -231.63 Million |
| Stock-based compensation | 12.11 Million | 138.29 Million | 62.39 Million | 32.79 Million | 14.15 Million | 5.69 Million |
| Change in working capital | -946.75 Million | 79.07 Million | -769.24 Million | -462.17 Million | -290.88 Million | -55.43 Million |
| Other non-cash items | 5.59 Million | -25.45 Million | -29.91 Million | 73.33 Million | 70.97 Million | 8.14 Million |
| Investing Cash Flow | 1.08 Billion | 68.3 Million | -435.5 Million | 529.08 Million | -592.92 Million | -472.4 Million |
| Investments in PPE | -979.85 Million | -678 Million | -209.48 Million | -352.84 Million | -507.65 Million | -335.21 Million |
| Acquisitions | 906.2 Million | 335.19 Million | 44.64 Million | 120.17 Million | -154.3 Million | -20 Million |
| Investment purchases | -68.48 Million | -344.78 Million | -1.48 Billion | -103.77 Million | -1.67 Billion | -896.71 Million |
| Sales/Maturities of investments | 949.09 Million | 824.28 Million | 451.12 Million | 764.56 Million | 974.75 Million | 1.15 Billion |
| Other Investing Activities | -51.95 Million | -68.38 Million | 767.61 Million | 100.95 Million | 764.69 Million | -374.54 Million |
| Financing Cash Flow | -894.83 Million | -753.68 Million | -1.62 Billion | 2.35 Billion | -1.01 Billion | 311.28 Million |
| Debt repayment | -68.68 Million | -1.18 Billion | -2.46 Billion | -1.82 Billion | -2.02 Billion | -982.16 Million |
| Dividends payments | -419.21 Million | -391.29 Million | -391.29 Million | - | -912.05 Million | -549.05 Million |
| Common Stock Repurchased | -289.07 Million | - | - | - | 2.43 Billion | 1.87 Billion |
| Common Stock Issuance | - | - | - | 3 Billion | 43.91 Million | 13.84 Million |
| Other Financing Activities | -35.47 Million | 821.77 Million | 1.23 Billion | 1.17 Billion | -554.42 Million | -48 Million |
| Accounts receivables | -322.89 Million | 74.83 Million | -545.2 Million | -542.15 Million | -386.39 Million | -254.59 Million |
| Accounts payables | - | -74.83 Million | 545.2 Million | 542.15 Million | 386.39 Million | - |
| Inventory | -376.63 Million | -116.79 Million | -8.33 Million | -35.46 Million | -20.05 Million | -49.19 Million |
| Other working capital | -236.97 Million | 195.86 Million | -760.91 Million | -426.71 Million | -270.83 Million | -6.24 Million |
| Cash at beginning of period | 1.65 Billion | 973.13 Million | 3.27 Billion | 354.8 Million | 1.18 Billion | 572.58 Million |
| Cash at end of period | 2 Billion | 1.65 Billion | 973.13 Million | 3.27 Billion | 354.8 Million | 1.18 Billion |
| Capital Expenditure | -979.85 Million | -678 Million | -209.48 Million | -352.84 Million | -507.65 Million | -335.21 Million |
| Effect of forex changes on cash | 4.82 Million | 15.12 Million | -35.09 Million | -63.99 Million | 232 Thousand | 362 Thousand |
| Net cash flow / Change in cash | 348.85 Million | 684.46 Million | -2.29 Billion | 2.91 Billion | -832.84 Million | 615.06 Million |
| Free Cash Flow | -828.8 Million | 676.7 Million | -411.45 Million | -256.11 Million | 265.14 Million | 440.6 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 228.3 Million | 228.3 Million | 740.03 Million | -779.94 Million | -779.94 Million | 1.13 Billion |
| Depreciation & Amortization | 80.62 Million | 80.62 Million | 309.59 Million | 79.49 Million | 73.16 Million | 72.58 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 5.09 Million | 5.09 Million | 12.11 Million | -20.79 Million | -20.79 Million | 26.85 Million |
| Change in working capital | - | - | -946.75 Million | -468.25 Million | -468.25 Million | - |
| Other non-cash items | 117.3 Million | 117.3 Million | 5.59 Million | 1.3 Billion | 1.31 Billion | -1.27 Billion |
| Investing Cash Flow | -200.98 Million | -200.98 Million | 1.08 Billion | -132.14 Million | -132.14 Million | 676.05 Million |
| Investments in PPE | - | - | -979.85 Million | -241.59 Million | -241.59 Million | - |
| Acquisitions | - | - | 906.2 Million | - | - | - |
| Investment purchases | - | - | -68.48 Million | - | - | - |
| Sales/Maturities of investments | - | - | 949.09 Million | - | - | - |
| Other Investing Activities | -200.98 Million | -200.98 Million | -51.95 Million | 109.44 Million | 109.44 Million | 676.05 Million |
| Financing Cash Flow | 143.26 Million | 143.26 Million | -894.83 Million | -205.23 Million | -205.23 Million | -242.18 Million |
| Debt repayment | - | - | -68.68 Million | - | - | - |
| Dividends payments | - | - | -419.21 Million | -209.6 Million | -209.6 Million | - |
| Common Stock Repurchased | -200.87 Million | -200.87 Million | -289.07 Million | -120.02 Million | -120.02 Million | -24.51 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 344.13 Million | 344.13 Million | -35.47 Million | 124.39 Million | 124.39 Million | -217.66 Million |
| Accounts receivables | - | - | -322.89 Million | -161.44 Million | -161.44 Million | - |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | -376.63 Million | -188.31 Million | -188.31 Million | - |
| Other working capital | - | - | -236.97 Million | -118.48 Million | -118.48 Million | - |
| Cash at beginning of period | - | - | 1.65 Billion | - | - | - |
| Cash at end of period | 373.91 Million | 373.91 Million | 2 Billion | -219.92 Million | -219.92 Million | 394.34 Million |
| Capital Expenditure | - | - | -979.85 Million | -241.59 Million | -241.59 Million | - |
| Effect of forex changes on cash | 296 Thousand | 296 Thousand | 4.82 Million | 920.5 Thousand | 920.5 Thousand | 1.49 Million |
| Net cash flow / Change in cash | 373.91 Million | 373.91 Million | 348.85 Million | -219.92 Million | -219.92 Million | 394.34 Million |
| Free Cash Flow | 431.32 Million | 431.32 Million | -828.8 Million | -125.05 Million | -125.05 Million | -41.01 Million |
2601
605111
1785
GMBL
600612
DTSQU